Aberrant expression of ALK and EZH2 in Merkel cell carcinoma

T. Veija, V. Koljonen, T. Bohling, M. Kero, S. Knuutila, Virinder Kaur Sarhadi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number236
JournalBMC Cancer
Number of pages9
Publication statusPublished - 31 Mar 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • ALK
  • EZH2
  • Merkel cell carcinoma
  • Next-generation sequencing
  • RNA
  • 3122 Cancers
  • 3111 Biomedicine

Cite this